Pancholi, Sunil http://orcid.org/0000-0002-0880-1588
Simigdala, Nikiana
Ribas, Ricardo
Schuster, Eugene
Leal, Mariana Ferreira
Nikitorowicz-Buniak, Joanna
Rega, Camilla
Bihani, Teeru
Patel, Hitisha
Johnston, Stephen R.
Dowsett, Mitch http://orcid.org/0000-0003-4122-744X
Martin, Lesley-Ann http://orcid.org/0000-0002-7606-4161
Funding for this research was provided by:
Breast Cancer Now
Article History
Received: 6 July 2021
Accepted: 7 October 2022
First Online: 29 November 2022
Competing interests
: S.R.J., M.D. and L.-A.M. receive academic funding from Pfizer, Puma Biotechnology Inc. and AstraZeneca. M.D. receives honoraria from Myriad Genetics and the speaker’s bureau of Roche, was a consultant and advisory board member of Radius, GTx and Orion Pharma, and has received remuneration from the ICR rewards to Inventors Schemes. S.R.J. is a consultant/independent contractor for AstraZeneca, Novartis, Pfizer, OBI, Eli Lilly and Company and is on the speaker’s bureau for OBI and Puma. L.-A.M. has also received honoraria from Eli Lilly, Pfizer and Novartis. T.B. and H.P. were employees and shareholders of Radius Health at the time of the study. There remaining authors declare no compting interests.